209 related articles for article (PubMed ID: 20406107)
21. Thyroglobulin assay 4 weeks after thyroidectomy predicts outcome in low-risk papillary thyroid carcinoma.
Giovanella L; Ceriani L; Ghelfo A; Keller F
Clin Chem Lab Med; 2005; 43(8):843-7. PubMed ID: 16201895
[TBL] [Abstract][Full Text] [Related]
22. False-Positive 131I Uptake in a Benign Bone Lesion on Post-therapy Scan.
Yazici B; Oral A; Eraslan C; Argin M; Ömür Ö
Clin Nucl Med; 2016 Jan; 41(1):e63-5. PubMed ID: 26252335
[TBL] [Abstract][Full Text] [Related]
23. Reinduction of cell differentiation and 131I uptake in a poorly differentiated thyroid tumor in response to the reverse transcriptase (RT) inhibitor nevirapine.
Modoni S; Landriscina M; Fabiano A; Fersini A; Urbano N; Ambrosi A; Cignarelli M
Cancer Biother Radiopharm; 2007 Apr; 22(2):289-95. PubMed ID: 17600478
[TBL] [Abstract][Full Text] [Related]
24. Prophylactic lymph node dissection for papillary thyroid cancer less than 2 cm: implications for radioiodine treatment.
Bonnet S; Hartl D; Leboulleux S; Baudin E; Lumbroso JD; Al Ghuzlan A; Chami L; Schlumberger M; Travagli JP
J Clin Endocrinol Metab; 2009 Apr; 94(4):1162-7. PubMed ID: 19116234
[TBL] [Abstract][Full Text] [Related]
25. Sensitivity of 123I whole-body scan and thyroglobulin in the detection of metastases or recurrent differentiated thyroid cancer.
de Geus-Oei LF; Oei HY; Hennemann G; Krenning EP
Eur J Nucl Med Mol Imaging; 2002 Jun; 29(6):768-74. PubMed ID: 12029550
[TBL] [Abstract][Full Text] [Related]
26. Exophytic and ulcerated local recurrence of papillary thyroid carcinoma with spectacular response to external beam radiotherapy.
Gkountouvas A; Thomas D; Tertipi A; Chrysanthou K; Kaldrimidis P
Thyroid; 2008 Sep; 18(9):1015-6. PubMed ID: 18788923
[TBL] [Abstract][Full Text] [Related]
27. Is diagnostic iodine-131 scanning useful after total thyroid ablation for differentiated thyroid cancer?
Cailleux AF; Baudin E; Travagli JP; Ricard M; Schlumberger M
J Clin Endocrinol Metab; 2000 Jan; 85(1):175-8. PubMed ID: 10634383
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of thyroglobulin after thyroidectomy before ablative radioiodine therapy in thyroid cancer.
Grünwald F; Menzel C; Fimmers R; Zamora PO; Biersack HJ
J Nucl Med; 1996 Dec; 37(12):1962-4. PubMed ID: 8970514
[TBL] [Abstract][Full Text] [Related]
29. Are there disadvantages in administering 131I ablation therapy in patients with differentiated thyroid carcinoma without a preablative diagnostic 131I whole-body scan?
Salvatori M; Perotti G; Rufini V; Maussier ML; Dottorini M
Clin Endocrinol (Oxf); 2004 Dec; 61(6):704-10. PubMed ID: 15579184
[TBL] [Abstract][Full Text] [Related]
30. Effect of a diagnostic dose of 185 MBq 131I on postsurgical thyroid remnants.
Bajén MT; Mañé S; Muñoz A; García JR
J Nucl Med; 2000 Dec; 41(12):2038-42. PubMed ID: 11138690
[TBL] [Abstract][Full Text] [Related]
31. Incidental finding of ovarian teratoma on post-therapy scan for papillary thyroid cancer and impact of SPECT/CT imaging.
Jammah AA; Driedger A; Rachinsky I
Arq Bras Endocrinol Metabol; 2011 Oct; 55(7):490-3. PubMed ID: 22147099
[TBL] [Abstract][Full Text] [Related]
32. Nuclear medicine approaches in the monitoring of thyroid cancer patients.
Sergieva S; Hadjieva T; Doldurova M; Stefanova S; Dudov A
J BUON; 2006; 11(4):511-8. PubMed ID: 17309186
[TBL] [Abstract][Full Text] [Related]
33. Thyroglobulin and 131I uptake of remaining tissue in patients with differentiated carcinoma after thyroidectomy.
Moser E; Fritsch S; Braun S
Nucl Med Commun; 1988 Apr; 9(4):262-6. PubMed ID: 3399222
[TBL] [Abstract][Full Text] [Related]
34. False-positive whole-body scan after I-131 therapy in a patient with intestinal scar.
Sioka C; Dimakopoulos N; Kouraklis G; Kotsalou I; Zouboulidis A
Clin Nucl Med; 2006 Apr; 31(4):232-3. PubMed ID: 16550026
[TBL] [Abstract][Full Text] [Related]
35. False-positive 131I whole-body scan in well-differentiated thyroid cancer patient with respiratory bronchiolitis.
Thientunyakit T
Clin Nucl Med; 2013 Sep; 38(9):730-4. PubMed ID: 23510883
[TBL] [Abstract][Full Text] [Related]
36. Neck recurrence from thyroid carcinoma: serum thyroglobulin and high-dose total body scan are not reliable criteria for cure after radioiodine treatment.
Bachelot A; Leboulleux S; Baudin E; Hartl DM; Caillou B; Travagli JP; Schlumberger M
Clin Endocrinol (Oxf); 2005 Mar; 62(3):376-9. PubMed ID: 15730423
[TBL] [Abstract][Full Text] [Related]
37. Should 'low-risk' thyroid cancer patients with residual thyroglobulin be re-treated with iodine 131?
Hindié E; Zanotti-Fregonara P; Duron F; Keller I; Bouchard P; Devaux JY
Clin Endocrinol (Oxf); 2007 Mar; 66(3):329-34. PubMed ID: 17302864
[TBL] [Abstract][Full Text] [Related]
38. Littoral cell angioma presenting as metastatic thyroid carcinoma to the spleen.
Mohan V; Jones RC; Drake AJ; Daly PL; Shakir KM
Thyroid; 2005 Feb; 15(2):170-5. PubMed ID: 15753678
[TBL] [Abstract][Full Text] [Related]
39. [Papillary thyroid carcinoma in a median ectopic thyroid associated with intra-abdominal thyroid tissue].
Hoffmann R; Bubeck B; Raue F
Dtsch Med Wochenschr; 1991 Apr; 116(17):654-8. PubMed ID: 1902162
[TBL] [Abstract][Full Text] [Related]
40. [Pericardial effusion as a possible cause of false positives in I-131 radionuclide scans].
López Aznar D; García Sanchís L; Rivas Sánchez A; Alonso Monfort J; Hervás Benito I; Mateo Navarro A
Rev Esp Med Nucl; 1998; 17(3):158-61. PubMed ID: 9683854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
